Free Trial

Vital Farms (NASDAQ:VITL) Posts Earnings Results, Beats Estimates By $0.11 EPS

Vital Farms logo with Consumer Staples background

Vital Farms (NASDAQ:VITL - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.26 by $0.11, Zacks reports. The company had revenue of $162.19 million during the quarter, compared to the consensus estimate of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The firm's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period last year, the firm earned $0.43 EPS. Vital Farms updated its FY 2025 guidance to EPS.

Vital Farms Price Performance

Shares of NASDAQ VITL traded up $1.25 during trading on Friday, reaching $33.82. The company had a trading volume of 973,778 shares, compared to its average volume of 1,035,005. Vital Farms has a 52 week low of $27.91 and a 52 week high of $48.41. The business's 50 day moving average price is $32.50 and its 200-day moving average price is $35.07. The stock has a market cap of $1.51 billion, a PE ratio of 30.20 and a beta of 0.94. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24.

Analysts Set New Price Targets

Several research firms have recently weighed in on VITL. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a research note on Tuesday. Morgan Stanley cut their price objective on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. DA Davidson lowered their target price on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a report on Friday, March 14th. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target for the company in a report on Friday, February 28th. Finally, William Blair restated an "outperform" rating on shares of Vital Farms in a research report on Friday, February 28th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Vital Farms presently has a consensus rating of "Buy" and an average target price of $44.63.

View Our Latest Research Report on Vital Farms

Insider Activity

In other news, insider Matthew Ohayer sold 20,000 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $29.46, for a total value of $589,200.00. Following the transaction, the insider now owns 6,970,890 shares of the company's stock, valued at approximately $205,362,419.40. This trade represents a 0.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Russell Diez-Canseco sold 45,124 shares of Vital Farms stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the sale, the chief executive officer now owns 703,736 shares of the company's stock, valued at approximately $23,708,865.84. This represents a 6.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 93,124 shares of company stock valued at $3,019,308 over the last three months. 27.60% of the stock is owned by insiders.

About Vital Farms

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

See Also

Earnings History for Vital Farms (NASDAQ:VITL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines